BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 31266633)

  • 1. SIX4 acts as a master regulator of oncogenes that promotes tumorigenesis in non-small-cell lung cancer cells.
    Tang X; Yang Y; Song X; Liu X; Wang X; Huang F; Li Y; Chen F; Wan H
    Biochem Biophys Res Commun; 2019 Aug; 516(3):851-857. PubMed ID: 31266633
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Circular RNA-hsa-circ-0000670 promotes gastric cancer progression through the microRNA-384/SIX4 axis.
    Liu P; Cai S; Li N
    Exp Cell Res; 2020 Sep; 394(2):112141. PubMed ID: 32535033
    [TBL] [Abstract][Full Text] [Related]  

  • 3. MiRNA-621 inhibits the malignant progression of non-small cell lung cancer via targeting SIX4.
    Zhang M; Shi H; Zhang C; Zhang SQ
    Eur Rev Med Pharmacol Sci; 2019 Jun; 23(11):4807-4814. PubMed ID: 31210312
    [TBL] [Abstract][Full Text] [Related]  

  • 4. NT5DC2 suppression restrains progression towards metastasis of non-small-cell lung cancer through regulation p53 signaling.
    Jin X; Liu X; Zhang Z; Xu L
    Biochem Biophys Res Commun; 2020 Dec; 533(3):354-361. PubMed ID: 32962856
    [TBL] [Abstract][Full Text] [Related]  

  • 5. IGF2BP3‑stabilized SIX4 promotes the proliferation, migration, invasion and tube formation of ovarian cancer cells.
    Han J; Hu X
    Mol Med Rep; 2022 Jul; 26(1):. PubMed ID: 35616130
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Role of high expression levels of STK39 in the growth, migration and invasion of non-small cell type lung cancer cells.
    Li Z; Zhu W; Xiong L; Yu X; Chen X; Lin Q
    Oncotarget; 2016 Sep; 7(38):61366-61377. PubMed ID: 27542260
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Interferon regulatory factor 4 (IRF4) is overexpressed in human non‑small cell lung cancer (NSCLC) and activates the Notch signaling pathway.
    Qian Y; Du Z; Xing Y; Zhou T; Chen T; Shi M
    Mol Med Rep; 2017 Nov; 16(5):6034-6040. PubMed ID: 28849037
    [TBL] [Abstract][Full Text] [Related]  

  • 8. B-Myb Mediates Proliferation and Migration of Non-Small-Cell Lung Cancer via Suppressing IGFBP3.
    Fan X; Wang Y; Jiang T; Cai W; Jin Y; Niu Y; Zhu H; Bu Y
    Int J Mol Sci; 2018 May; 19(5):. PubMed ID: 29772705
    [TBL] [Abstract][Full Text] [Related]  

  • 9. miR-802 inhibits the proliferation, invasion, and epithelial-mesenchymal transition of glioblastoma multiforme cells by directly targeting SIX4.
    Huang W; Shi Y; Han B; Wang Q; Zhang B; Qi C; Liu F
    Cell Biochem Funct; 2020 Jan; 38(1):66-76. PubMed ID: 31702057
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The expression profile and clinic significance of the SIX family in non-small cell lung cancer.
    Liu Q; Li A; Tian Y; Liu Y; Li T; Zhang C; Wu JD; Han X; Wu K
    J Hematol Oncol; 2016 Nov; 9(1):119. PubMed ID: 27821176
    [TBL] [Abstract][Full Text] [Related]  

  • 11. B-Myb Is Up-Regulated and Promotes Cell Growth and Motility in Non-Small Cell Lung Cancer.
    Jin Y; Zhu H; Cai W; Fan X; Wang Y; Niu Y; Song F; Bu Y
    Int J Mol Sci; 2017 May; 18(6):. PubMed ID: 28555007
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Long noncoding RNA XIST acts as an oncogene in non-small cell lung cancer by epigenetically repressing KLF2 expression.
    Fang J; Sun CC; Gong C
    Biochem Biophys Res Commun; 2016 Sep; 478(2):811-7. PubMed ID: 27501756
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evaluation of role of Notch3 signaling pathway in human lung cancer cells.
    Hassan WA; Yoshida R; Kudoh S; Motooka Y; Ito T
    J Cancer Res Clin Oncol; 2016 May; 142(5):981-93. PubMed ID: 26838758
    [TBL] [Abstract][Full Text] [Related]  

  • 14. FOXP4 modulates tumor growth and independently associates with miR-138 in non-small cell lung cancer cells.
    Yang T; Li H; Thakur A; Chen T; Xue J; Li D; Chen M
    Tumour Biol; 2015 Sep; 36(10):8185-91. PubMed ID: 25994569
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of microRNA-135a on Cell Proliferation, Migration, Invasion, Apoptosis and Tumor Angiogenesis Through the IGF-1/PI3K/Akt Signaling Pathway in Non-Small Cell Lung Cancer.
    Zhou Y; Li S; Li J; Wang D; Li Q
    Cell Physiol Biochem; 2017; 42(4):1431-1446. PubMed ID: 28715819
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Homeobox C8 is a transcriptional repressor of E-cadherin gene expression in non-small cell lung cancer.
    Zhang J; Yang M; Li D; Zhu S; Zou J; Xu S; Wang Y; Shi J; Li Y
    Int J Biochem Cell Biol; 2019 Sep; 114():105557. PubMed ID: 31202850
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Knockdown of STIM1 expression inhibits non-small-cell lung cancer cell proliferation
    Ge C; Zeng B; Li R; Li Z; Fu Q; Wang W; Wang Z; Dong S; Lai Z; Wang Y; Xue Y; Guo J; Di T; Song X
    Bioengineered; 2019 Dec; 10(1):425-436. PubMed ID: 31564210
    [TBL] [Abstract][Full Text] [Related]  

  • 18. CHD4 mediates proliferation and migration of non-small cell lung cancer via the RhoA/ROCK pathway by regulating PHF5A.
    Xu N; Liu F; Wu S; Ye M; Ge H; Zhang M; Song Y; Tong L; Zhou J; Bai C
    BMC Cancer; 2020 Mar; 20(1):262. PubMed ID: 32228507
    [TBL] [Abstract][Full Text] [Related]  

  • 19. MicroRNA-1197 downregulation inhibits proliferation and migration in human non- small cell lung cancer cells by upregulating HOXC11.
    Sun B; Hua J; Cui H; Liu H; Zhang K; Zhou H
    Biomed Pharmacother; 2019 Sep; 117():109041. PubMed ID: 31181445
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Phosphorylation of nucleolin is indispensable to its involvement in the proliferation and migration of non-small cell lung cancer cells.
    Huang F; Wu Y; Tan H; Guo T; Zhang K; Li D; Tong Z
    Oncol Rep; 2019 Jan; 41(1):590-598. PubMed ID: 30320343
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.